Changhao Xie

422 citations
38 papers · 269 indexed · h-index 9
Topics
Systemic Lupus Erythematosus Research (18 papers)T-cell and B-cell Immunology (8 papers)Cytokine Signaling Pathways and Interactions (7 papers)
Partner nations
China

In The Last Decade

Changhao Xie

32 papers receiving 265 citations

Peers

Changhao Xie
Comparison fields: 5 of 79
  • Immunology 103
  • Molecular Biology 89
  • Rheumatology 87
  • Oncology 35
  • Pharmacology 27
Replace Shangxue Yan with:
Shangxue Yan China
Qi Tan China
Hongyu Jie China
Hidetaka Ishino Japan
Huilin Yang China
Zihao Li China
Huimin Ding China
Yuanli Zhu China
Yasumi Kitahara Japan
Changhao Xie relative to Shangxue Yan China Shangxue Yan's profile →
Citations per field
00.5×1.5×2.4×
Shangxue Yan · 1×
Citations per year

Countries citing papers authored by Changhao Xie

Since Specialization
Citations

This map shows the geographic impact of Changhao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhao Xie more than expected).

Fields of papers citing papers by Changhao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changhao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhao Xie. The network helps show where Changhao Xie may publish in the future.

Co-authorship network of co-authors of Changhao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Changhao Xie. A scholar is included among the top collaborators of Changhao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changhao Xie. Changhao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 0
5 1
6 3
7 8
8 8
9 3
10 2
11 4
12 41
13 0
14 14
15
[The Study of Protective Effect of Paeoniflorin on Lung Injury in MRL/lpr Mice].
1
16 14
17 21
18
[Paeoniflorin ameliorates liver injury of MRL/lpr mice through inhibition of NF-κB pathway].
3
19 1
20 17

About Changhao Xie

Changhao Xie is a scholar working on Rheumatology, Complementary and Manual Therapy and Immunology, having authored 38 papers that have together received 269 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (18 papers), T-cell and B-cell Immunology (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Rheumatology (87 citations), Immunology (103 citations) and Pharmacology (24 citations). Changhao Xie has collaborated with scholars based in China. Frequent co-authors include Zhijun Li, Baiqing Li, Tao Wang, Hongtao Wang, Hao Liu, Zhuo Chen, Yun Yu, Ying Wang, Fang Wei and Qing Wang. Their work appears in journals such as The Journal of Immunology, Scientific Reports and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026